Katharine Yao to Combined Modality Therapy
This is a "connection" page, showing publications Katharine Yao has written about Combined Modality Therapy.
Connection Strength
1.091
-
Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075.
Score: 0.494
-
ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Ann Surg Oncol. 2021 12; 28(Suppl 3):572-573.
Score: 0.157
-
Treatment delays from transfers of care and their impact on breast cancer quality measures. Breast Cancer Res Treat. 2019 Feb; 173(3):603-617.
Score: 0.127
-
Surgery and hormone therapy trends in octogenarians with invasive breast cancer. Am J Surg. 2016 Mar; 211(3):541-5.
Score: 0.104
-
Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
Score: 0.099
-
Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009 Feb; 89(1):267-81, xi.
Score: 0.064
-
Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. Breast Cancer Res Treat. 2017 04; 162(2):317-328.
Score: 0.028
-
Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. J Am Coll Surg. 2011 Jul; 213(1):122-8; discussion 128-9.
Score: 0.019